TMFBiologyFool

Brian Orelli

Somewhere between his graduate thesis on BRCA1, a gene that causes hereditary breast cancer, and his postdoctoral fellowship in DNA repair, Brian realized he enjoyed analyzing other people's data more than running his own experiments. Having gotten his first taste of how to analyze stocks from The Motley Fool many years prior, it was only fitting that he came full circle and started writing about biotech, pharmaceutical, and medical device companies for Fool.com. He also covers the health insurance industry to keep from going into binary-event overload. When not writing at The Motley Fool or trade journals like Nature Biotechnology and BioWorld, Brian can be found coaching soccer or hanging out at the beach in his hometown of San Diego.

TMFBiologyFool’s Activity

Today

NL

Article

TMFBiologyFool published an article 2 hours ago

Why bluebird bio Inc. Slipped Lower Today

A dilutive stock offering and comments from President-elect Donald Trump had the biotech's shares trading lower.

Yesterday

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 9:29 PM

Mon Dec 5

NL

Article

TMFBiologyFool published an article 1:37 PM

Why Agios Pharmaceuticals Inc Stock Fell Sharply Today

The biotech is the big loser from the American Society of Hematology meeting.

NL

Article

TMFBiologyFool published an article 10:03 AM

Biotech's Dumbest CEO Moves in 2016

The industry leaders' mistakes are lessons for investors.

Thu Dec 1

NL

Article

TMFBiologyFool published an article 4:45 PM

Here's the Best Dividend Stock in Big Pharma

To be best, a drugmaker needs more than just a large dividend.

NL

Article

TMFBiologyFool published an article 10:18 AM

Gilead Sciences, Inc.'s $10 Billion Mistake

The biotech's worst purchase of 2016.

Sat Nov 26

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 6:29 PM

Wed Nov 23

Rule Breakers article.

TMFBiologyFool published an update. 2:28 PM

NL

Article

TMFBiologyFool published an article 2:05 PM

Why Juno Therapeutics Inc Plummeted Today

Another clinical hold on one of the biotech's CAR-T clinical trials has investors hitting the sell button.

Tue Nov 22

NL

Article

TMFBiologyFool published an article 4:30 PM

What Happened in Biotech in 2016?

Lessons from the year give biotech investors clues on what to look for next year.

Mon Nov 21

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 11:53 AM

Supernova Boards Post

TMFBiologyFool replied to the Supernova boards. 2:41 AM

Fri Nov 18

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 5:30 PM

Thu Nov 17

NL

Article

TMFBiologyFool published an article 4:20 PM

Better Buy: Juno Therapeutics vs. bluebird bio

A battle of two platform drugmakers.

Wed Nov 16

Stock Advisor Boards Post

TMFBiologyFool replied to the Stock Advisor boards. 6:05 PM

Stock Advisor Boards Post

TMFBiologyFool posted to the Stock Advisor boards. 2:16 PM

Tue Nov 15

Rule Breakers Boards Post

TMFBiologyFool replied to the Rule Breakers boards. 7:11 PM

Supernova Boards Post

TMFBiologyFool posted to the Supernova boards. 3:30 AM

Mon Nov 14

NL

Article

TMFBiologyFool published an article 3:55 PM

Why Celldex Therapeutics, Inc. Stock Jumped Higher Again Today

Seeming anything -- including preclinical data -- will spark shares of the beaten-down biotech.

NL

Article

TMFBiologyFool published an article 1:03 PM

Why Corbus Pharmaceuticals Holdings Inc. Skyrocketed Higher Today

Positive phase 2 data from the small biotech sends shares higher.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 78.12
Player Rank 16358 out of 74751
Score 330.36
Score Change Today -152.94
Accuracy 66.67%
Active Picks 71
Total Picks 215
Best Pick UNH (+299.81)
Worst Pick INCY (-967.96)
Average Score per Pick 1.54
Charms Earned 9
Highest Rated Favorite zzlangerhans
Go to TMFBiologyFool’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts CAPS All Star SN Explorer 1 Mission Team Member SN Odyssey
Board Posts 1360
Recs Received 2133
People who have rec'd these posts 625
Recs to Posts Ratio (last 30 days) N/A
Threads Started 142
Threads Started Percentage 10.44 %
Most Frequent Board Motley Fool Supernova
Very First Post Re: How many is enough? (6/6/2001)
Percentage of Posts Rec'd 56.99 %
Show TMFBiologyFool’s 10 Latest Posts